Delivery Order SPE2DB22D9112-SPE2DB24FE6RM

Award Date 2/16/24
Potential Completion Date 3/11/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $11,605.50, is for the supply of XOLAIR 150 MG/ML SYRINGEML. This order is placed under a larger indefinite delivery contract, #4600082013, which DMS Pharmaceutical Group holds with DLA under the SPE2DB program. That contract, valued up to $4,999,999 through 2025, allows DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $4,642.20, is for the delivery of XOLAIR 150 MG/ML SYRINGEML to support the medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $30,948.00 contract is for the delivery of 4,564,287,720 units of XOLAIR 150 MG/ML SYRINGE/ML, a pharmaceutical product. The delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB24D9238, valued at up to $4,999,999 that DMS Pharmaceutical Group holds with the DLA. This...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,189.60 contract is for the delivery of XOLAIR 150 MG/ML SYRINGE. This award is part of a larger indefinite delivery vehicle (IDV) contract, #4600082013, valued up to $4,999,999 through 2025, that allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support...
This federal contract award is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,189.60 order is for the provision of 4565784008 - XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,313.45 contract is for the delivery of XOLAIR 150 MG/ML SYRINGE injectable medication, with a period of performance through August 26, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,642.20 contract is for the delivery of XOLAIR 150 MG/ML SYRINGE medication. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue orders for a wide range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,189.60 to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,642.20 contract is for the delivery of XOLAIR 150 MG/ML SYRINGE, a pharmaceutical product, with a period of performance through July 17, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB24FE6RM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The $6,189.60 firm fixed-price contract is for the provision of XOLAIR 150 MG/ML SYRINGE syringes. This order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025. The IDV allows DLA to issue delivery orders for a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities globally. This particular award does not have a set-aside designation.

Generated 5/17/24, 10:31 AM